{"id":14649,"date":"2025-10-07T15:01:17","date_gmt":"2025-10-07T09:31:17","guid":{"rendered":"https:\/\/www.torusdigital.com\/toruscope\/?p=14649"},"modified":"2026-01-07T12:46:28","modified_gmt":"2026-01-07T07:16:28","slug":"fabtech-technologies-ipo-gets-a-flat-opening","status":"publish","type":"post","link":"https:\/\/www.torusdigital.com\/toruscope\/news\/fabtech-technologies-ipo-gets-a-flat-opening\/","title":{"rendered":"Fabtech Technologies IPO Listing: Stock Opens Marginally Above Issue Price, Early Dip of 5%"},"content":{"rendered":"

[vc_section el_id=”blog-inner-layout”][vc_row overlay_dotted=””][vc_column el_class=”blog_primary”][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

Fabtech Technologies Limited, a leading biopharma engineering company, made its stock market debut on Tuesday, October 7, 2025, following the completion of its initial public offering (IPO). Shares of Fabtech Technologies<\/a> were listed at \u20b9192 apiece on the National Stock Exchange (NSE), marking a modest premium of \u20b91 or 0.5% over the issue price of \u20b9191. On the Bombay Stock Exchange (BSE), the shares also opened at \u20b9192 per share. However, shortly after listing, the stock witnessed a decline of approximately 5%, touching an intraday low of \u20b9181.45 on BSE and \u20b9182.40 on NSE, reflecting early market volatility.<\/p>\n

<\/span>Subscription and IPO Details<\/strong><\/span><\/h3>\n

The Fabtech Technologies IPO<\/a> was priced in the range of \u20b9181 to \u20b9191 per share, comprising a fresh issue of 12.1 million equity shares, entirely consisting of new shares. There was no offer-for-sale (OFS) component in this IPO. Investors were able to bid in lots of 75 shares. The subscription window was open from September 29 to October 1, 2025, and the basis of allotment was finalised on October 3, 2025.<\/p>\n

The offering saw strong participation from multiple investor segments. Overall subscription stood at 2.03 times, with retail investors leading at 2.08 times oversubscription, followed by Qualified Institutional Buyers (QIBs) at 2.03 times and Non-Institutional Investors (NIIs) at 1.97 times. This indicates steady investor interest despite the modest listing gains.<\/p>\n

<\/span>Use of IPO Proceeds<\/strong><\/span><\/h3>\n

According to the Red Herring Prospectus (RHP), Fabtech Technologies intends to utilise the net proceeds from the IPO for a combination of business needs. Approximately \u20b9127 crore will be allocated to fund working capital requirements, while \u20b930 crore is earmarked for inorganic growth through strategic acquisitions. The remaining funds are planned for general corporate purposes, supporting the company\u2019s expansion and operational objectives.<\/p>\n

<\/span>Management and Advisors<\/strong><\/span><\/h3>\n

Bigshare Services served as the registrar for the IPO<\/a>, ensuring smooth allotment and share transfer processes, while Unistone Capital acted as the sole book-running lead manager, overseeing the successful execution of the offering.<\/p>\n


\n\"\"
\n<\/a><\/p>\n